吉林敖東(000623.SZ):全資子公司創新醫藥科技擬引入中榮凱特為戰投
格隆匯1月26日丨吉林敖東(000623.SZ)宣佈,公司於2021年1月25日召開2021年第一次董事長辦公會,會議審議通過了《關於全資子公司吉林敖東創新醫藥科技有限公司增資擴股暨引進戰略投資者的議案》,同意公司全資子公司吉林敖東創新醫藥科技有限公司(簡稱“創新醫藥科技”)以增資擴股方式引入戰略投資者中榮凱特(北京)生物科技有限公司(簡稱“中榮凱特”)。
中榮凱特擬以貨幣資金形式出資人民幣2000萬元投資創新醫藥科技,並與創新醫藥科技簽署《股權認購協議》。創新醫藥科技該次增資擴股完成後,註冊資本變更為人民幣5000萬元,中榮凱特認繳出資額為人民幣2000萬元,佔創新醫藥科技註冊資本的40%。
創新醫藥科技成立於2019年09月20日,註冊資本3000萬人民幣,法定代表人王永寬,經營範圍包括藥品研發、銷售;醫藥研究和試驗發展、技術開發、諮詢、交流、轉讓、推廣服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.